Recombinant factor VIIa: a general hemostatic agent? Yes.
Roberts
H R
HR
Division of Hematology/Oncology, Department of Medicine and The Carolina Cardiovascular Biology Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7035, USA. hrr@med.unc.edu
D003029:Coagulants / Q000627:therapeutic use; D020147:Coagulation Protein Disorders / Q000188:drug therapy; D005167:Factor VII / Q000627:therapeutic use*; D005168:Factor VII Deficiency / Q000188:drug therapy; D015942:Factor VIIa; D006467:Hemophilia A / Q000188:drug therapy; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use*
D003029:Coagulants; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa